Max Healthcare Institute Limited (MAXHEALTH) — key facts
NSE-listed · Healthcare. Data as of 11 Nov 2026 (IST) from InvestSights.
Last close: ₹915 (-1.19% day change)
Key ratios
- P/E ratio
- 61.66
- P/B ratio
- 8.71
- ROE (%)
- 13.42
- ROCE (%)
- 11.94
- Debt/Equity
- 0.32
- Dividend yield (%)
- 0.16
- Market cap (₹ Cr)
- 89,057.87
Forensic checks
Piotroski F-Score: 8/9 · Altman Z-Score: 6.43 · Beneish M-Score: -2.25
InvestSights quality score
62.8/100 — Above Average (descriptive data-driven composite; not a recommendation)
Management guidance track record
- Max Lucknow bed expansion: guided 550beds, delivered 500beds (FY26) — missed guidance
- Max Smart 400-bed brownfield commissioning: guided 400beds, delivered 200beds (Q1 FY27) — missed guidance
Latest earnings call (Q2 FY27)
AI summary: The central signal is that Max Healthcare’s brownfield expansion model is absorbing capacity rapidly enough to protect network occupancy and support operating leverage, but the next phase introduces greater greenfield and regulatory uncertainty. Occupancy held at 77% despite a 14% increase in operational beds, while Max Smart’s 260 beds reached EBITDA breakeven within three…
Full analysis on InvestSights
InvestSights is an analytics platform and is not SEBI-registered as a Research Analyst or Investment Adviser. All figures are educational, descriptive data — not investment advice. Consult a SEBI-registered adviser before investing.